Cart (0 Items)
Your cart is currently empty.
View ProductsNews
No posts found.
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Blog
Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide
Read more -
CAR-T cell therapy
CAR-T cell engineering: strategies to overcome remaining limitations
Read more -
Custom Antibody
Monoclonal vs. Polyclonal Antibodies: What’s the Difference?
Read more
-
Antibody-drug conjugates
Everything you need to know about the generation of antibody-drug conjugates (ADCs)
Read more -
CAR-T cell therapy
CAR-T cell engineering: strategies to overcome remaining limitations
Read more -
Antibody production
Fundamental and advanced methods to improve monoclonal antibody production in vitro
Read more -
Antibody production
The untapped potential of bispecific antibody therapies
Read more -
Antibody production
What are the leading monoclonal antibody treatments for cancer?
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more